Tencent Securities News (Bei Xiang)Shisiyao GroupThis morning, the share price rose as much as 6% to HK $5.08, an all-time high. As of press time, Shisiyao Group rose 3.13% to HK $4.94.

Source: Futu Securities

The company announced that the group has obtained the drug production registration approval of Sodium Acetate Ringer injection (500ml) from the State Food and Drug Administration. Sodium acetate Ringer injection is mainly used to treat blood loss caused by trauma, surgery and burns. It belongs to the sixth category of original chemicals.

Source: company announcement

The current group's L-AppleAPIs such as acid, azithromycin, linezolid, pinvastatin calcium, Arbidol hydrochloride, moxifloxacin hydrochloride, tirofiban hydrochloride, bromohexine hydrochloride and hydroxyethyl starch 2000.5 have obtained relevant registration numbers.

CICC said in a previous research report that Shangtiaishi Pharmaceutical Group's earnings per share forecast for 2017 was 5% to 0.22 Hong Kong dollars, leaving the 2018 earnings per share forecast unchanged at 0.28 Hong Kong dollars. Considering that its financial indicators such as gross margin, net margin and ROE are better than their peers, the target price is raised by 8.60% to HK $5.43, with the new target price corresponding to 24 times and 19 times forecast 2017 and 2018 earnings ratios, maintaining the "recommended" rating. (editor / Golden Forest)